Slowdown in probiotics business weighs on Chr. Hansen shares

Chr Hansen Holding A/S

08/07/2021 08:37

** Shares in Danish supplier of food cultures, probiotics
and enzymes Chr. Hansen  CHRH.CO  are down 5.2% despite Q3 beat
 urn:newsml:reuters.com:*:nASN001F9Q
    ** The company delivered Q3 revenue and underlying EBIT
above consensus but according to JP Morgan Q4 guide was weak
    ** The broker points to inventories-induced slowdown within
Human Health, the company's probiotic business, that is expected
to drive Q4 like-for-like sales "below expectations"
    ** The stock is on track for its worst day since March 2020
and at the bottom of Copenhagen blue chip index  .OMXC20 

 (Reporting by Izabela Niemiec)
 ((Izabela.niemiec@tr.com))